Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROSHARES TRUST (ZBIO) Capital Expenditures: 2023-2024

Historic Capital Expenditures for Zenas BioPharma (ZBIO) over the last 2 years, with Dec 2024 value amounting to $131,000.

  • Zenas BioPharma's Capital Expenditures fell 18.18% to $18,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $149,000, marking a year-over-year change of. This contributed to the annual value of $131,000 for FY2024, which is 670.59% up from last year.
  • As of FY2024, Zenas BioPharma's Capital Expenditures stood at $131,000, which was up 670.59% from $17,000 recorded in FY2023.
  • Zenas BioPharma's Capital Expenditures' 5-year high stood at $131,000 during FY2024, with a 5-year trough of $17,000 in FY2023.
  • Its 2-year average for Capital Expenditures is $74,000, with a median of $74,000 in 2023.
  • Data for Zenas BioPharma's Capital Expenditures shows a peak YoY soared of 670.59% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Zenas BioPharma's Capital Expenditures stood at $17,000 in 2023, then surged by 670.59% to $131,000 in 2024.